CAMBRIDGE, Mass., Oct. 11, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. INFI will be presenting at the BIO Investor Forum on Wednesday, October 17, 2018, at 11:15 a.m. PT (2:15 p.m. ET) in San Francisco, CA. A live webcast of the presentation will be available on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About Infinity

Infinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:

Stephanie Ascher, Stern Investor Relations, Inc.

212-362-1200 or Stephanie@sternir.com

View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-bio-investor-forum-300729176.html

SOURCE Infinity Pharmaceuticals, Inc.